APA

Loren A. W., Luger S. M., Stadtmauer E. A., Tsai D. E., Schuster S., Nasta S. D., Goldstein S. C., Perl A., Orloff G., Oliver J. C., Green J., Emerson S. G. & Porter D. L. (20050818). Intensive graft-versus-host disease prophylaxis is required after unrelated-donor nonmyeloablative stem cell transplantation. : Bone marrow transplantation.

Chicago

Loren A W, Luger S M, Stadtmauer E A, Tsai D E, Schuster S, Nasta S D, Goldstein S C, Perl A, Orloff G, Oliver J C, Green J, Emerson S G and Porter D L. 20050818. Intensive graft-versus-host disease prophylaxis is required after unrelated-donor nonmyeloablative stem cell transplantation. : Bone marrow transplantation.

Harvard

Loren A. W., Luger S. M., Stadtmauer E. A., Tsai D. E., Schuster S., Nasta S. D., Goldstein S. C., Perl A., Orloff G., Oliver J. C., Green J., Emerson S. G. and Porter D. L. (20050818). Intensive graft-versus-host disease prophylaxis is required after unrelated-donor nonmyeloablative stem cell transplantation. : Bone marrow transplantation.

MLA

Loren A W, Luger S M, Stadtmauer E A, Tsai D E, Schuster S, Nasta S D, Goldstein S C, Perl A, Orloff G, Oliver J C, Green J, Emerson S G and Porter D L. Intensive graft-versus-host disease prophylaxis is required after unrelated-donor nonmyeloablative stem cell transplantation. : Bone marrow transplantation. 20050818.